Future Market Insights, a leading market research firm, has revealed a promising outlook for the global automated cell biology systems industry. According to their recent analysis, the market, currently valued at an estimated US$ 14.1 Billion, is poised for substantial growth, projecting an impressive Compound Annual Growth Rate (CAGR) of 9.0% over the forecast period. The market is anticipated to reach an estimated valuation of around US$ 33.5 Billion by the year 2032.
The exponential growth in the automated cell biology systems market can be attributed to the continuous development of powerful technologies and applications, propelled by the widespread adoption of laboratory automation. This trend has emerged as a major force in the biotechnology sector, shaping the landscape of research and production.
Request A Sample Copy Of This Research Report! https://www.futuremarketinsights.com/reports/sample/rep-gb-15816
One of the key drivers for the increased demand in automated cell biology systems is the critical role they play in advancing personalized therapies. As the biotechnology sector strives for cost-effectiveness and widespread accessibility of customized treatments, automation in research and production becomes a prerequisite. The ability to streamline processes through automation not only enhances efficiency but also contributes significantly to the scalability and affordability of personalized therapies.
The anticipated CAGR of 9.0% reflects the industry’s resilience and adaptability in a rapidly evolving landscape. This growth trajectory is underpinned by the continuous innovation and advancements in technology, as well as the increasing recognition of the importance of personalized therapies in the healthcare sector.
In conclusion, the global automated cell biology systems market is on the verge of a transformative journey, with projections pointing towards a remarkable growth story. As we move towards 2032, the industry is expected to play a pivotal role in shaping the future of biotechnology, with a focus on personalized therapies and the broader accessibility of customized treatments.
Key Takeaways from Market Study:
- Automated cell counters (single function) are the leading segment as product, and hold approximately 34.6% market share in 2021, as they provide accurate cell counts.
- Drug development applications hold a market share of around 35.4% in 2021, owed to robust growth of biopharmaceutical industry.
- Infinite cell line cultures account for around 76.2% in 2021, as they are easy to culture than primary cell cultures.
- Biopharmaceutical companies as prime end users hold a share of around 27.4% in 2021, owed to growing CMO/CDMO activities for drug manufacturing.
- North America holds a dominant share of 37.4% in 2021, owed to a high economic output in the region.
“Rising Demand for Personalized Medicine, and Growth in Total Lab Automation Techniques will Propel Overall Market Growth,” Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)
Our Analyst Is Available To Help You With Any Inquiries You May Have! https://www.futuremarketinsights.com/ask-question/rep-gb-15816
Market Competition:
Automated cell biology system manufacturers have been substantially investing in research to offer long-term solutions for both the biopharmaceutical and packaging industries. Players in the automated cell biology systems market are also focusing on innovations and alliances to strengthen their market position.
For instance:
- In September 2022, Thermo Fisher Scientific Inc. launched the Thermo Scientific™ DynaSpin™ Single-Use Centrifuge system.
- Corning Incorporated introduced a reliable method for differentiating monocytes into dendritic cells in October 2019 with the introduction of Corning® MicroDEN, an automated perfusion cell culture system.
Key Companies Profiled:
- Thermo Fisher Scientific
- Corning Incorporated
- Merck KGaA
- Lonza
- Sartorius AG
- Hitachi. Ltd
- Nanoentek
- ChemoMetec
- Danaher corporation
- Agilent Technologies
- Perkin Elmer (Nexcelom Bioscience LLC.)
- F. Hoffmann-La Roche AG
- SHIMADZU CORPORATION
- Bio-Rad Laboratories
- Miltenyi Biotec
- Sinfonia Technology
Discover the Future of Marketing: Get Your Hands on Our Customization Report! https://www.futuremarketinsights.com/customization-available/rep-gb-15816
Key Market Segments Covered in Automated Cell Biology Systems Industry Research:
By Product:
- Cell Culture Process Automatization Instrument or Robot (Multiple Function)
- Automated Bioreactor (Single or Multiple Function)
- Automated Cell Culture Media Exchange System (Single Function)
- Automated Culture Media Analyzer (Single Function)
- Automated Cell Wash-and-Concentrate System (Single Function)
- Automated Cell Counter (Single Function)
- Automated Fill And Finish System (Single Function)
- Automated Cell Storage Equipment (Single Function)
- Management Software
By Cell Culture:
- Finite Cell Line Cultures
- Infinite Cell Line Cultures
By Application:
- Cell Therapy
- Drug Development
- Stem Cell Research
- Regenerative Medicine
By End User:
- Mega Pharmaceutical companies
- Biopharmaceutical companies
- CDMOs/CMOs
- Research organizations
- Academic institutes
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
Gain Immediate Access to Detailed Market Insights: Purchase Now! https://www.futuremarketinsights.com/checkout/15816
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
